Medically reviewed by Michael MacIntyre, MD Schizophrenia medication falls under two main categories: older, first-generation ...

Explore the most effective treatments for Tourette syndrome, including behavioral therapy, medications, and advanced care ...

Beta-blockers are one of the first-line medications often prescribed for migraine prevention. Discover the benefits, side ...

Williams, W. R. (2025) Nucleotide Relative Molecular Similarity within Anti-Psychotic Drug Structures. Journal of Biosciences and Medicines, 13, 106-117. doi: 10.4236/jbm.2025.136010 .

Bristol Myers Squibb’s Cobenfy failed to outdistance a placebo in a Phase 3 test that evaluated the drug as an adjunct to antipsychotics in schizophrenia patients. Last September, the FDA ...

The US Food and Drug Administration (FDA) has approved Cobenfy (Bristol Myers Squibb), a first-in-class antipsychotic approved for schizophrenia.The drug targets cholinergic receptors as opposed ...

“The dogma has been that antipsychotic drugs preferentially affect striatal neurons that express D2 dopamine receptors,” said lead author Jones Parker in a statement at the time. “Instead, a ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach. By Ellen Barry and Christina Jewett The Food and Drug Administration on ...

Most prescription antipsychotic medications work by blocking the class of brain receptors that respond to the neurotransmitter dopamine—a cornerstone molecule of the brain’s reward system and ...